Wellington Management Group
NUVB icon

Wellington Management Group’s Nuvation Bio NUVB Stock Holding History

Wellington Management Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.07M Buy
715,781
+43,637
+6% +$213K ﹤0.01% 1492
2026
Q1 		$2.88M Sell
672,144
-227,844
-25% -$1.27M ﹤0.01% 1495
2025
Q4 		$8.06M Buy
899,988
+31,458
+4% +$195K ﹤0.01% 1305
2025
Q3 		$3.21M Buy
868,530
+134,988
+18% +$368K ﹤0.01% 1529
2025
Q2 		$1.43M Buy
733,542
+40,869
+6% +$85.1K ﹤0.01% 1656
2025
Q1 		$1.22M Buy
692,673
+16,649
+2% +$37.9K ﹤0.01% 1663
2024
Q4 		$1.8M Buy
676,024
+52,051
+8% +$134K ﹤0.01% 1590
2024
Q3 		$1.43M Buy
623,973
+283,642
+83% +$865K ﹤0.01% 1641
2024
Q2 		$994K Buy
+340,331
New +$1.04M ﹤0.01% 1679
2021
Q2 		– Sell
-808,325
Closed -$8.22M – 2208
2021
Q1 		$8.22M Buy
+808,325
New +$9.04M ﹤0.01% 1294

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Wellington Management Group's NUVB Position: Q2 2026 in Review

Wellington Management Group increased its Nuvation Bio (NUVB) stake by 6.5% in Q2 2026, buying an estimated $213K and bringing the position to 715,781 shares worth $4.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1492.

Wellington Management Group first reported a position in NUVB in Q1 2021 and has held it in 10 quarters since. The position peaked at $8.22M in Q1 2021. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Wellington Management Group held 715,781 shares of Nuvation Bio worth $4.07M as of Q2 2026.
  • Wellington Management Group bought 43,637 Nuvation Bio shares in Q2 2026, an estimated $213K.
  • Nuvation Bio made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1492 holding.
  • Wellington Management Group first reported a position in Nuvation Bio in Q1 2021 and has held it in 10 quarters since.
  • Wellington Management Group's Nuvation Bio position peaked at $8.22M in Q1 2021.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.